Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 30 of 6351
-
Phone alerts and therapy sessions aim to prevent suicide after hospital discharge
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a combination of brief digital and clinician-delivered interventions can help adults leaving a psychiatric hospitalization cope with suicidal thoughts and prevent suicide-related events. The main questions it aims to answer are…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could your own fat cells fight Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThe goal of this Phase 2 clinical trial is to learn if repeated dosing of RB-ADSC (an investigational autologous cell product obtained from participant's own adipose tissue) enhances the positive preliminary results seen in Phase 1 for the of treatment for mild to moderate Alzhei…
Phase 2 • Sponsor: Regeneration Biomedical, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New heart valve device aims to fix tricuspid leak without open surgery
Disease control Not yet recruitingThe purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevant tricuspid regurgitation who are suitable for valve replacement.
Sponsor: TRiCares • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a drug combo spare bladder cancer patients from surgery?
Disease control Not yet recruitingRadical cystectomy remains the standard curative-intent treatment for most patients with muscle-invasive bladder cancer, but it is associated with significant morbidity and long-term quality-of-life implications. Trimodality therapy is an accepted standard-of-care alternative for…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple drug tame the dangerous side effects of CAR-T cancer therapy?
Disease control CancelledObjectives: The primary objective of this study will be to evaluate the impact of pre-emptive use of anakinra on the rate of severe cytokine release syndrome (CRS) following CD19-directed chimeric antigen receptor (CAR) T-cell therapy for B-acute lymphoblastic leukemia (B-ALL) in…
Phase 1/2 • Sponsor: Kevin McNerney • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo aims to stall advanced prostate cancer
Disease control Not yet recruitingThe primary objective of this study is to measure efficacy of saruparib + physician's choice of ARPI compared with placebo + ARPI in men with metastatic hormone-sensitive prostate cancer (mHSPC) who have previously received docetaxel chemotherapy or a prostate-specific membrane a…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Heating the body to fight pancreatic cancer: a new trial tests Whole-Body hyperthermia
Disease control Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and limited treatment options following failure of first-line therapy. Whole-body hyperthermia (WBHT) is a non-invasive treatment approach that raises the body's core temperature under controlled conditions…
Phase 2/3 • Sponsor: ElmediX • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Psilocybin and brain training: a new frontier for aging minds?
Symptom relief Not yet recruitingBackground: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also wan…
Phase 2 • Sponsor: National Institute on Aging (NIA) • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can engineered immune cells tame stubborn autoimmune diseases?
Disease control Not yet recruitingTherapy with chimeric antigen receptor T (CAR-T) cells has demonstrated activity against refractory autoimmune disease, however not all disease responds or remains in response to CD19 targeted CAR-T cells. We posit that CAR-T cells expressing BAFF (BAFF CAR-T cells) can become an…
Phase 1 • Sponsor: Luminary Therapeutics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A simple breath test might spot multiple cancers before symptoms appear
Diagnosis Not yet recruitingThe purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.
Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Can a lower dose of a myeloma drug keep the disease in check with fewer side effects?
Disease control Not yet recruitingThis study is testing whether a lower dose of belantamab mafodotin used together with pomalidomide and dexamethasone can provide similar effectiveness with fewer side effects compared with the standard dose in patients with relapsed or refractory multiple myeloma. Participants w…
Phase 2 • Sponsor: Polish Myeloma Consortium • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can an ancient herbal pill improve outcomes after a bleeding stroke?
Disease control Not yet recruitingIn this domain of APEX-STROKE, participants with acute intracerebral hemorrhage (ICH) who meet the eligibility criteria for this domain will be randomized in a 1:1 ratio to receive either Angong Niuhuang pills (ANP) or matching placebo, both in addition to guideline-based standar…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Rapid-Acting clot blocker boost stroke recovery?
Disease control Not yet recruitingIschemic stroke accounts for the majority of stroke cases in China, and moderate ischemic stroke (NIHSS 4-10) carries a high risk of early neurologic deterioration (END) and long-term disability. Although intensified antiplatelet strategies reduce END, they have not consistently …
Phase 4 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
A shot at safer CAR t: early brain protection for lymphoma patients?
Disease control Not yet recruitingThe goal of this clinical trial is to reduce the duration of ICANS and incidence of G3 or great ICANS in participants who receive axi-cel. The main questions the study aims to answer are: Efficacy of IT therapy to reduce high-grade ICANS in participants who receive axi-cel in NHL…
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a Four-Drug combo tackle a tough liver cancer?
Disease control Not yet recruitingThe purpose of this study is to learn how well a combination of iparomlimab and tuvonralimab (QL1706), lenvatinib, radiotherapy, and hepatic arterial infusion chemotherapy (HAIC) works and how safe it is for people with hepatocellular carcinoma (HCC) that has grown into the porta…
Phase 2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A graft that grows? new vessel may spare infants repeat surgeries
Cure Not yet recruitingThe purpose of this study is to test the safety and performance of a new blood vessel graft, called the ATEV. The graft is designed to reconnect the heart to the lungs and to grow as the child grows, which may eliminate the need for future surgeries.
Phase 1/2 • Sponsor: Joseph Dearani • Aim: Cure
Last updated Aug 27, 2026 00:00 UTC
-
Dye-Guided surgery may spare healthy lymph nodes in esophageal cancer
Disease control Not yet recruitingIn the comprehensive treatment system for esophageal cancer, surgical resection combined with regional lymph node dissection remains the core component for achieving cure in patients with resectable esophageal squamous cell carcinoma (ESCC). The traditional surgical concept holds…
Phase 3 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Two-Pronged immune attack outsmart stomach cancer?
Disease control Not yet recruitingThis is a multicenter, randomized Phase II window-of-opportunity study evaluating rilvegostomig (AZD2936) in patients with treatment-naïve, HER2-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma with PD-L1 CPS ≥1. Rilvegost…
Phase 2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a T-Cell engager open the door to more kidney transplants?
Disease control Not yet recruitingThis investigator-initiated, single-arm, open-label Phase IIa pilot study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of OM336 in highly HLA-sensitized adults with chronic kidney disease awaiting kidney transplantation. The…
Phase 2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can radiation spare the brain while fighting cancer in the spinal fluid?
Disease control Not yet recruitingThe purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal metastases from solid tumors.
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC